HR

Hardeo Ram Kaler

Active Director Director DIN 01997486
DIN 01997486 First appointment Sep 2005 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Sep 2005
Shareholding value •••• Premium profile

About Hardeo Ram Kaler

Data last updated:

Hardeo Ram Kaler is a Director at Safe And Cure Superspecialities Hospital Private Limited (since 2018), Director at Deevee Marbles Private Limited (since 2012) and Director at Frontline Infratech Private Limited (since 2011). The companies operate in Healthcare, Mining and Construction. The 3 current companies with reported revenue have a combined latest revenue of ₹2.95 Cr; the largest is Safe And Cure Superspecialities Hospital Private Limited at ₹2.60 Cr (FY 2023). Earlier, Hardeo Ram Kaler was a Director at Tenfold Pharmaceuticals Private Limited (2005–2010).

DIN 01997486
Primary Designation Director
Industry Healthcare
First Appointment 13 Sep 2005
Oldest Company Age 32 yrs
Largest company Safe And Cure Superspecialities Hospital Private Limited · ₹2.60 Cr (FY 2023)
Combined revenue ₹2.95 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Jul 20182018₹2.60 Cr (FY 2023)Active
Deevee Marbles Private Limited U14101RJ1994PTC008359
Director01 Feb 20121994₹34.7 Lakh (FY 2023)Active
Frontline Infratech Private Limited U70101RJ2011PTC033910
Director20 Jan 20112011₹51,660 (FY 2023)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Sep 20052005₹86.7 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Deevee Marbles Private Limited
Frontline Infratech Private Limited
Safe And Cure Superspecialities Hospital Private Limited
Tenfold Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Hardeo Ram Kaler

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hardeo Ram Kaler

Hardeo Ram Kaler currently holds 3 directorships: Safe And Cure Superspecialities Hospital Private Limited (Director, since 12 Jul 2018, revenue ₹2.60 Cr (FY 2023)); Deevee Marbles Private Limited (Director, since 01 Feb 2012, revenue ₹34.7 Lakh (FY 2023)); Frontline Infratech Private Limited (Director, since 20 Jan 2011, revenue ₹51,660 (FY 2023)).

Hardeo Ram Kaler was first appointed on 13 Sep 2005 as Director at Tenfold Pharmaceuticals Private Limited. The most recent appointment on record is 12 Jul 2018 at Safe And Cure Superspecialities Hospital Private Limited.

The 3 current companies of Hardeo Ram Kaler that report revenue have a combined latest revenue of ₹2.95 Cr: Safe And Cure Superspecialities Hospital Private Limited ₹2.60 Cr (FY 2023); Deevee Marbles Private Limited ₹34.7 Lakh (FY 2023); Frontline Infratech Private Limited ₹51,660 (FY 2023).

Hardeo Ram Kaler held 1 earlier board appointment: Tenfold Pharmaceuticals Private Limited (Director, 13 Sep 2005 to 11 Feb 2010).

The current boards of Hardeo Ram Kaler's companies include Radha Devi Kaler (Safe And Cure Superspecialities Hospital Private Limited), Sucheta Kaler (Safe And Cure Superspecialities Hospital Private Limited), Vivek Kaler (Safe And Cure Superspecialities Hospital Private Limited), Deepti Dhayal (Deevee Marbles Private Limited), Gordhan Singh (Deevee Marbles Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available